Laser-assisted delivery of tranexamic acid for melasma
December 23, 2020

Findings from two recent pilot studies suggest 1927 nm fractional thulium fiber laser-assisted topical tranexamic acid delivery is a safe, effective melasma treatment option.

Targeting melasma’s vascular component improves treatment outcomes, prevent relapse
December 18, 2020

Dermatologists should consider assessing melasma patients for increased vascularity and include antivascular treatments to improve outcomes among patients whose lesions have a vascular component. 

Cysteamine cream, tranexamic acid mesotherapy reveal similar efficacy, different safety
October 14, 2020

Cysteamine cream and tranexamic acid mesotherapy demonstrated similar efficacy but yielded different safety results when being compared as a treatment for melasma, according to a recently published study.